Top 50 Health Care VC Funds & Investors in Hong Kong (November 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
SOSV
VC Fund
|
6 | United States, China, Canada | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Software | $25k–$5M |
|
Gobi Partners
VC Fund
|
6 | China, Hong Kong, Malaysia | Venture - Series Unknown, Series A, Seed | E-Commerce, Financial Services, Software | $300k–$100M |
|
Alibaba Entrepreneurs Fund
VC Fund
|
6 | Hong Kong, Taiwan, United States | Series A, Seed, Series B | Artificial Intelligence, Software, E-Commerce | $510k–$150M |
|
FJ Labs
VC Fund
|
4 | United States, United Kingdom, Brazil | Seed, Series A, Series B | Software, E-Commerce, Financial Services | $1.2M–$65M |
|
Artesian VC
VC Fund
|
4 | Australia, United States, China | Seed, Pre-Seed, Venture - Series Unknown | Software, Health Care, Artificial Intelligence | $29k–$17M |
|
Deep Knowledge Group
VC Fund
|
4 | United Kingdom, United States, Hong Kong | Seed, Convertible Note | Health Care, Biotechnology, Market Research | |
|
Qiming Venture Partners
VC Fund
|
4 | China, United States, Hong Kong | Series A, Series B, Series C | Health Care, Biotechnology, Medical | $4M–$120M |
|
5Y Capital
VC Fund
|
3 | China, United States, India | Series A, Series B, Series C | Artificial Intelligence, Software, Biotechnology | $2.4M–$400M |
|
Medi Ventures
VC Fund
|
3 | Poland, Hong Kong | Seed, Angel, Pre-Seed | Manufacturing, Medical Device, Health Diagnostics | $218k–$3M |
|
Orbit Ventures
VC Fund
|
3 | China, United States, India | Seed, Pre-Seed, Convertible Note | E-Commerce, Software, Artificial Intelligence | $30k–$20M |
|
Particle Accelerator Limited (ParticleX)
VC Fund
|
3 | Hong Kong, United States, Taiwan | Seed, Pre-Seed, Series A | Artificial Intelligence, Software, Information Technology | $430k–$11M |
|
Apricot Capital
VC Fund
|
3 | China, United States, Hong Kong | Series A, Seed, Series B | Health Care, Biotechnology, Medical | $3M–$90M |
|
Coent Venture Partners
VC Fund
|
2 | Japan, Taiwan, Hong Kong | Seed, Angel, Series A | Software, Information Technology, Education | $275k–$10M |
|
Lilly Asia Ventures
VC Fund
|
2 | China, United States, Hong Kong | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $14M–$308M |
|
BioVenture
VC Fund
|
2 | China, United States, Hong Kong | Series A, Series B, Seed | Health Care, Biotechnology, Medical | $4.4M–$85M |
|
Groove Capital
VC Fund
|
2 | United States, Hong Kong, Mauritius | Seed, Pre-Seed, Series A | Software, Health Care, Information Technology | $100k–$3.3M |
|
Hony Capital
VC Fund
|
2 | China, United States, Hong Kong | Series A, Series B, Seed | Manufacturing, Biotechnology, Medical | $3.8M–$646M |
|
Cowin Venture
VC Fund
|
2 | China, United States, Hong Kong | Series A, Angel, Series B | Health Care, Biotechnology, Medical | $52k–$257M |
|
HSG
VC Fund
|
2 | China, United States, Singapore | Series A, Series B, Seed | Artificial Intelligence, Health Care, Software | $2M–$200M |
|
StartUp Health
VC Fund
|
2 | United States, Canada, United Kingdom | Seed, Venture - Series Unknown, Pre-Seed | Health Care, Medical, Wellness | $20k–$15M |
|
Arkansas Development Finance Authority
VC Fund
|
2 | United States | Venture - Series Unknown, Seed, Pre-Seed | Medical, Biotechnology, Manufacturing | $2M–$35M |
|
Picus Capital
VC Fund
|
2 | United States, Germany, United Kingdom | Seed, Series A, Pre-Seed | Software, Financial Services, FinTech | $563k–$34M |
|
FEBE Ventures
VC Fund
|
2 | Singapore, Indonesia, Vietnam | Seed, Series A, Pre-Seed | FinTech, Financial Services, Software | $400k–$40M |
|
Med-Fine Capital
VC Fund
|
2 | China, Hong Kong, United States | Series A, Seed, Series B | Medical, Health Care, Biotechnology | $3M–$60M |
|
FHB Ventures
VC Fund
|
2 | United States | Seed, Series A, Series B | Agriculture, AgTech, Medical | |
|
Vectr
VC Fund
|
2 | United States, Hong Kong, Singapore | Seed, Series A, Series B | FinTech, Financial Services, Artificial Intelligence | $547k–$70M |
|
Novel Tycoon
VC Fund
|
2 | Hong Kong | Seed | Nutrition, Organic Food, Food Processing | $1.3M–$1.3M |
|
Whist Subholdings
VC Fund
|
2 | United States | Seed, Venture - Series Unknown | Medical, Agriculture, Health Care | |
|
Chartwell Ventures
VC Fund
|
2 | Hong Kong | Seed | Nutrition, Organic Food, Food Processing | $1.3M–$1.3M |
|
Simmons Foods
VC Fund
|
2 | United States | Seed, Venture - Series Unknown | Medical, Agriculture, Health Care | |
|
AAIC Ventures
VC Fund
|
2 | Hong Kong, Egypt, Kenya | Seed, Series A | Medical, DIY, iOS | $350k–$2M |
|
PT Medion
VC Fund
|
2 | United States | Seed, Venture - Series Unknown | Medical, Agriculture, Health Care | |
|
Seveno Capital
VC Fund
|
2 | Japan, Hong Kong, United Kingdom | Seed, Pre-Seed, Venture - Series Unknown | Sensor, Travel, Wearables | |
|
Capital Union Investments
VC Fund
|
2 | United States, Hong Kong | Seed, Series A, Series B | Health Care, Marketing, Personal Health | $150k–$10M |
|
Bold Capital Partners
VC Fund
|
2 | United States, Hong Kong, India | Series A, Series B, Seed | Health Care, Software, Biotechnology | $2M–$58M |
|
Hillhouse Investment
VC Fund
|
1 | China, United States, Singapore | Series B, Series A, Series C | Biotechnology, Health Care, Software | $2.9M–$230M |
|
Vector Ventures
VC Fund
|
1 | Hong Kong | Seed | Mining, Nutrition, Oil and Gas | $1.3M–$2M |
|
Emerging Technology Partners
VC Fund
|
1 | United States, China, Hong Kong | Series A, Series B, Seed | Health Care, Biotechnology, Medical | $1M–$40M |
|
WuXi AppTec
VC Fund
|
1 | United States, China, Israel | Series A, Series B, Series C | Biotechnology, Pharmaceutical, Health Care | $6M–$130M |
|
Alon Capital Ltd
VC Fund
|
1 | Hong Kong | Series A | Biopharma, Life Science, Biotechnology | |
|
AEF Greater Bay Area Fund
VC Fund
|
1 | Hong Kong, China, Macao | Seed, Series A, Series B | Biotechnology, Sports, Sustainability | |
|
GrowthX
VC Fund
|
1 | United States, Canada, Italy | Seed, Convertible Note, Angel | Software, SaaS, Machine Learning | |
|
PRYTEK
VC Fund
|
1 | Israel, United States, United Kingdom | Series A, Seed | Software, FinTech, Information Technology | |
|
Betatron Venture Group
VC Fund
|
1 | Hong Kong, India, Singapore | Seed, Series A, Pre-Seed | Information Technology, Software, E-Commerce | |
|
Juvenescence
VC Fund
|
1 | United States, Hong Kong, Isle of Man | Series A, Debt Financing | Biotechnology, Pharmaceutical, Health Care | $3M–$19M |
|
SFUND
VC Fund
|
1 | China, Hong Kong, United States | Angel, Series A, Post-IPO Equity | Manufacturing, Agriculture, Medical Device | |
|
Maverick Ventures
VC Fund
|
1 | United States, Israel, India | Series A, Series C, Seed | Health Care, Medical, Biotechnology | |
|
Cowin Capital
VC Fund
|
1 | China, Hong Kong, United States | Series A, Series B, Seed | Manufacturing, Health Care, Biotechnology | $1.4M–$50M |
|
DNA Capital
VC Fund
|
1 | United States, Brazil, China | Seed, Series A, Series B | Health Care, Medical, Hospital | $250k–$30M |
|
Iflytek
VC Fund
|
1 | China, Hong Kong | Series A, Angel, Seed | Artificial Intelligence, Information Technology, Software | $142k–$99M |
| Access all 309 VC funds in Hong Kong Health Care startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
SOSV offers pre-seed capital and follow-on financial support to startups focusing on deep technology and scientific innovation. Founders utilize purpose-built laboratory facilities and engineering spaces to accelerate product development and testing. The firm facilitates connections between entrepreneurs and a network of investors through structured matchmaking events and technology summits.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, China, Canada
Investor stats
- Total investments: 3821
- Round size: Seed $125k–$5M; Pre-Seed $25k–$1.5M; Convertible Note $50k–$3.6M
- Lead/follow: 38% lead, 62% follow
- Last fund: Likely still investing — raised $306M in 2023
Portfolio highlights
- Halla — Halla Intelligence is a digital solution that leverages over 100 billion shopper and product data points to recommend and promote what grocery items.
- Verdex Technologies — Verdex Technologies is an advanced materials platform technology that uses nanofibers to disrupt industries. Verdex doesn't just compete, it innovates and disrupts.
- Samphire Neuroscience — Samphire Neuroscience builds clinically validated neurotechnology to support women across their lives. Our wearable devices, Nettle™ and Lutea™, are built on the same underlying brain-stimulation technology, targeting neural pathways involved in pain, mood, stress, and sleep regulation. - Lutea™ is available globally as a wellness device. Itstimulates the same regions of the brain to support stress regulation, sleep, and recovery - key drivers of readiness and long-term performance - allowing athletes and teams to move beyond wellbeing education alone to practical, evidence-based intervention. - Nettle™ is a CE-marked (EU and UK regulated), drug- and hormone-free device that has been clinically shown to improve pain, mood, functionality, and the ability to train during the menstrual cycle, with measurable benefits after one month of use - supporting athletes to maintain training intensity and movement quality during their period. - The Samphire App is the platform controlling all Samphire hardware products with the use of CycleSync™ AI technology: the only one of its kind to support personalized neurotechnology use for women.
Gobi Partners is an Asia-focused VC backing early to growth stage startups. US$1.6B AUM, 400+ companies, 75 exits. Strategic guidance, founder network available.
Show more...Investment focus
- Industry: E-Commerce, Financial Services, Software
- Stage:Venture - Series Unknown, Series A, Seed
- Geography: China, Hong Kong, Malaysia
Investor stats
- Total investments: 436
- Round size: Seed $300k–$8M; Series A $1.6M–$16M; Venture - Series Unknown $1.1M–$100M
- Lead/follow: 28% lead, 72% follow
- Last fund: Likely still investing — raised $1.3B in 2023
Portfolio highlights
- Yuan Planet — Youdi is a second-hand auto parts trading platform.
- Camera360 — Camera360 is a mobile photo editing and selfie camera app that offers filters, beautification, and creative effects. It uses AI-based features like face detection, skin smoothing, beautification, and auto-enhancement to improve photos. The app also includes AI-powered effects such as makeup filters, portrait retouching, and scene optimization for images.
- nanoSkunkWorkx — nanoSkunkWorkX develops nanotechnology for AGI scaling and allergy biosensing.
The Entrepreneurs Fund is a not-for-profit initiative launched by Alibaba Group in 2015 to help entrepreneurs and young graduates realize their dreams and vision. Two separate funds have been set up in Hong Kong and Taiwan respectively to support specific programs in each place.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, E-Commerce
- Stage:Series A, Seed, Series B
- Geography: Hong Kong, Taiwan, United States
Investor stats
- Total investments: 82
- Round size: Seed $510k–$8M; Series A $2M–$15M; Series B $7M–$150M
- Lead/follow: 44% lead, 56% follow
- Last fund: May invest from a new fund soon — raised $130M in 2015
Portfolio highlights
- Tiiny AI — Tiiny AI offers a ready-to-use open-source ecosystem with one-click installation for models.
- Vpon Holdings — Vpon AI Big Data group helps companies discover opportunities with the power of data. Reliable Data, Smarter Analysis, Precise Planning for Measurable Results
- Neolix — Neolix is a technologically innovative company that specializes in the production of physical and sports scenes. Neolithic Century Technology is an innovative design team. Committed to design research, industrial design, structural engineering, product customization, providing customers with creative value enhancement services. Service customersinclude Lenovo, Siemens, Midea, GE, State Grid, CSIC, Honeywell, Bank of China, Agricultural Bank, etc.
FJ Labs is a stage-agnostic investment firm that focuses on marketplaces and consumer facing startups.
Show more...Investment focus
- Industry: Software, E-Commerce, Financial Services
- Stage:Seed, Series A, Series B
- Geography: United States, United Kingdom, Brazil
Investor stats
- Total investments: 1819
- Round size: Seed $1.2M–$9.8M; Series A $5M–$30M; Series B $10M–$65M
- Lead/follow: 3% lead, 97% follow
- Last fund: May invest from a new fund soon — raised $5.5M in 2016
Portfolio highlights
- HUNTY — HUNTY is a platform that help people find jobs by connecting them with world class mentors who prepare them for the job search process. And people only pay when they get hired.
- Goodweek — The AI management platform that gives partners and businesses one secure place for every AI model.
- Clarity Care AI — Clarity Care AI develops healthcare artificial intelligence software that supports care delivery and operations. The platform assists clinicians and care teams with documentation, task management, and communication around patient needs. Features include note drafting, summarization of patient information, and notifications that flag items requiring follow-up. Integrations connect to existing tools to streamline handoffs and keep records consistent across teams. Analytics highlight trends in patient status and operational workload to inform daily decisions. Implementation services, training resources, and ongoing product support help healthcare organizations adopt and use the software.
Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff. Since 2004, Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets. In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai. In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: Australia, United States, China
Investor stats
- Total investments: 659
- Round size: Seed $40k–$4M; Pre-Seed $29k–$535k; Venture - Series Unknown $650k–$17M
- Lead/follow: 37% lead, 63% follow
- Last fund: Likely still investing — raised $36M in 2023
Portfolio highlights
- Vaulta — Vaulta is a battery casing technology company based in Brisbane, Australia. Using advanced composite materials and smart, streamlined design, Vaulta has developed a lighter and smaller battery case with fewer parts, creating scalable efficiencies and opportunities for manufacturers. Vaulta founder and director Dominic Spooner has over 12 yearsexperience as a design engineer, and has worked in a range of industries, including renewables and batteries, defence and aerospace, consumer products, commercial products and startups. While working in battery design, Dominic saw firsthand that opportunities for growth were being overlooked in favour of continuing with the status quo – and that’s when the idea for Vaulta was born.Vaulta’s world-first no-weld design means modules can be easily assembled and disassembled, cells reused and recycled, and new cells added as battery technology continues to evolve.From stationary storage and electric vehicles to defence, aerospace and beyond, Vaulta’s battery case technology works wherever batteries do.
- Coherence Neuro — Opto Biosystems specializes in the development of innovative healthcare technologies that bridge the gap between cancer neuroscience and bioelectronics. The company focuses on creating smaller, softer, and wireless biological interfaces designed to offer a new treatment modality. By leveraging advancements in neural engineering and bioelectronics,Opto Biosystems is dedicated to building new tools that interface with the body, aiming to improve patient outcomes in the healthcare sector. Their work includes exploring the stability of thin-film electrodes for neuromodulation, highlighting their commitment to advancing medical technology.
- Andromeda Robotics — At Andromeda, our personalised robot companions are helping Australian aged care teams bring joy and connection to residents to improve wellbeing.
Deep Knowledge Group is a data-driven consortium of commercial and non-profit organizations active on many fronts in the realm of DeepTech and Frontier Technologies (AI, Longevity, BioTech, Pharma, FinTech, GovTech, SpaceTech, FemTech, Data Science, InvestTech), ranging from scientific research to investment, entrepreneurship, analytics, consulting, media, philanthropy and more. As a mathematical corporation focused on building the bridge to the 5th Industrial Revolution, Deep Knowledge Group is decisively committed to DeepTech for Social Good, Techno-Philanthropy and DeepTech and Longevity Industry Financial Commoditization (establishing the core investment and financial industry infrastructure needed for the emergence of DeepTech and Longevity as fundamentally new asset classes). Deep Knowledge Group has been committed since 2014 to the corporate thesis of DeepTech for social impact, techno-ethical business for social good, and the continual reinvestment of profits into the expansion of our core Data Science, AI and analytics assets and the refinement of our financial-ecosystemic development projects (which we see as the major tool driving our Group’s further growth as a Data Science driven financial corporation with focus on Longevity and DeepTech). Our unique approach lies in combining ecosystemic financial innovations with sophisticated AI and Data Science technology development for DeepTech and Longevity Industry analysis, benchmarking and forecasting. We remain committed as always to developing and deploying reliably sophisticated and multidimensional Big Data analytics and AI driven technological forecasting and benchmarking of DeepTech, Longevity and related industries, pioneering the fundamental tools required for strategic decision making in these unprecedentedly complex and innovation-driven sectors, laying the foundation and basis for defining, thinking about and understanding the coming DeepTech Revolution. However, more than this, the Group remains just as decisively committed to the practical execution of many of these forecasted developments by establishing the core investment and financial industry infrastructure (platforms, indices, exchanges, financial instruments and derivatives) needed for accelerated and de-risked DeepTech and Longevity Industrialization, and their emergence as fundamentally new asset classes.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Market Research
- Stage:Seed, Convertible Note
- Geography: United Kingdom, United States, Hong Kong
Investor stats
- Total investments: 13
- Lead/follow: 38% lead, 62% follow
- Last fund: May invest from a new fund soon — raised $100M in 2015
Portfolio highlights
- Longevity Card — Health is the New Wealth. Launching Soon.
- Deep Pharma Intelligence — Deep Pharma Intelligence is a leading UK-based market intelligence agency focused on the emerging markets in the Pharmaceutical, Biotech, and Healthcare industries
- DeepTech and Longevity Industry Financial Advisors — ongevity and DeepTech Financial Advisors Ltd. is a leading advisory boutique focused on the Longevity and DeepTech industries. Its shareholders and senior managers have built up significant expertise in private and public capital markets, as well as a substantial network of companies operating in the industry. They provide intermediary financialservices that are deployed in the form of an interactive online semi-automated IT-platform designed for end-users of investment products and services. They serve as the WealthTech/InvestTech financial marketplace for professional investors, family offices, and institutional investors and provide industry-specific analytical systems to enable the significant optimisation of dealflow, stock selection, and execution capabilities for investors.The company is decisively committed to establishing the core investment and financial industry infrastructure (platforms, indices, exchanges, financial instruments and derivatives) needed to execute the concept of DeepTech and Longevity Financial Commoditization, reflected in its pursuit of a truly ecosystemic approach through its various financial service divisions to establish an integral financial infrastructure to support the commoditization of the DeepTech and Longevity Industries as fundamentally new asset classes.
Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong in China, and Singapore. Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companies in the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages. Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B, Series C
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 1233
- Round size: Series A $4M–$45M; Series B $7.6M–$90M; Series C $12M–$120M
- Lead/follow: 51% lead, 49% follow
- Last fund: Likely actively investing — fresh fund, raised $8M in 2026
Portfolio highlights
- Nice Tuan — Nice Tuan is an e-commerce platform that provides daily groceries and miscellaneous products.
- Windward Bio — Windward Bio is a clinical-stage, drug development company committed to improving outcomes for people living with serious immunological diseases.
- Shennapsi Artificial Intelligence Technology — Synapsor is a medical-grade wearable device research and development company, oriented to the AI+ medical and health field, and is committed to the development and manufacturing of AI-powered medical-grade smart wearable devices, including AI-ECG artificial intelligence. Diagnostic analysis system, CUMS uric acid blood glucose and cholesterolmonitoring system, etc. The company has recently received tens of millions of yuan in Series B investment, and the investor is Xiaomi Technology.
5Y Capital is a firm engaged in providing early-stage venture investments. It was formerly known as Morningside Venture Capital. The investment firm manages USD 5bn in dual-currency funds in USD and RMB, backed by world-renowned sovereign wealth funds, family offices, fund of funds, university endowments, pensions, and foundations. It is an investment firm of Morningside Group. It was headquartered in Xuhui, Shanghai, China in 2008 by Ken Shi and Richard Liu.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Biotechnology
- Stage:Series A, Series B, Series C
- Geography: China, United States, India
Investor stats
- Total investments: 371
- Round size: Series A $2.4M–$100M; Series B $10M–$150M; Series C $32M–$400M
- Lead/follow: 30% lead, 70% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- DaSouChe — DaSouChe is the AI application infrastructure for China’s used car industry. According to CIC, the Company has held an over 90% market share in operating systems for China’s used car dealers since at least 2021. Building on this digital foundation, DaSouChe further supports used car dealers with essential transaction services across theirworkflows. Beyond used car dealers, the Company also works with other auto merchants, including OEMs, authorized dealers and new car brokers. Its services further engage and benefit thousands of dealers’ collaborators, such as inspectors, transporters and other internet platforms, creating an ecosystem with used car dealers at its center. The Company’s unwavering focus on used car dealers’ success underpins everything it does and has made its mission critical to their business.
- Flowtica — Flowtica provides Scribe, an AI smart pen that records, highlights, tracks notes with FlowTran, and converts them into structured summaries.
- Today AI — Today is a company that develops an AI-powered assistant app integrated with user data, third-party integrations, and health tracking systems.
Medi Ventures aim to fuel breakthroughs in the medical world by investing and supporting healthcare startups
Show more...Investment focus
- Industry: Manufacturing, Medical Device, Health Diagnostics
- Stage:Seed, Angel, Pre-Seed
- Geography: Poland, Hong Kong
Investor stats
- Total investments: 14
- Round size: Seed $218k–$3M
- Lead/follow: 86% lead, 14% follow
Portfolio highlights
- Cannabibs — Cannabibs is a nanotechnology company that provides clinical trial drugs for the treatment of irritable bowel syndrome.
- MyCogress — MyCogress is a waste management company that offers cosmetic materials for sustainable and environmentally friendly products.
- Target Cells — Target Cells is a biotechnology company that provides stem cell research and cardiac regeneration services.
Orbit helps scale breakthrough startups from around the globe across emerging and frontier markets.
Show more...Investment focus
- Industry: E-Commerce, Software, Artificial Intelligence
- Stage:Seed, Pre-Seed, Convertible Note
- Geography: China, United States, India
Investor stats
- Total investments: 577
- Round size: Seed $100k–$2M; Pre-Seed $100k–$1M; Convertible Note $30k–$20M
- Lead/follow: 73% lead, 27% follow
- Last fund: Likely still investing — fund raised in 2024
Portfolio highlights
- i4TECH — Modular, scalable, fully managed manufacturing digital solutions that enable your AI adoption. Moving Industry 4.0 forwards with a unified, comprehensive data driven approach
- Qanary — Qanary is a digital second-opinion platform designed to help radiologists detect cancer at its earliest, most treatable stages.
- openmed — OpenMed provides digital healthcare services, telemedicine, pharmacy products, diagnostics, and medication delivery.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Particle Accelerator Limited (ParticleX) was founded in late 2017 by Shine Works. ParticleX is a tech-based startup investor and accelerator based in Hong Kong. ParticleX combines network, capital and research resources, accelerating the pace of innovative technology and helping the early-stage startups to win cross-border opportunities acrossAsia.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Information Technology
- Stage:Seed, Pre-Seed, Series A
- Geography: Hong Kong, United States, Taiwan
Investor stats
- Total investments: 30
- Round size: Seed $1.2M–$5.5M; Pre-Seed $430k–$1.6M; Series A $1M–$11M
- Lead/follow: 7% lead, 93% follow
Portfolio highlights
- KorrAI — KorrAI helps you analyze rapidly evolving geospatial data and accelerate mineral exploration timelines.
- MediConCen — MediConCen is a medical network that mobilize medical experts all over the world to serve the insured population without middleman. They revolutionize the current medical network with Blockchain technology. MediConCen liberalizes the existing heavily walled medical network with the use of Blockchain technology, allowing individual clinics to rejointhe insurance market with a one-stop solution. The next generation medical ecosystem starts right here.MediConCen aims to integrate all clinics, insured employees and business entities into a unified Blockchain ecosystem, making business truly efficient, transparent and trustworthy.
- Ephod Technology — Ephod Intelligence is fund managers' research copilot, offering investment hypothesis validation, and personalized trading signals to empower fundamental research.
Apricot Capital is an investment firm focused on investing in companies in the early and growing stages of the healthcare industry, including biopharmaceuticals, life sciences, medical devices, medical services, and diagnostics. Founded in 2015, Apricot Capital consists of more than 20 professionals and consultants with experience in the healthcare industry. Its professional background includes life sciences, medicine, finance and law.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Seed, Series B
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 47
- Round size: Seed $10M–$41M; Series A $3M–$54M; Series B $14M–$90M
- Lead/follow: 49% lead, 51% follow
- Last fund: Likely actively investing — fresh fund, raised $41M in 2025
Portfolio highlights
- iRegene — iRegene researches and develops pharmaceutical therapy for neurodegenerative and rare diseases.
- Zhiran Medical — Zhiran Medical is a medical technology company specializing in the precise detection and treatment of neurological disorders using high-throughput, flexible brain-computer interface technology.
- Microtide Biotechnology — Microtide Biotechnology is an innovative company specializing in the field of in vivo cell therapy. The company is dedicated to advancing next-generation biomedical technologies that harness the body’s own cellular mechanisms for disease treatment, focusing on developing safe, effective, and precise therapeutic solutions to improve patient outcomesand redefine the future of regenerative medicine.
Coent Venture Partners provides seed and venture-stage funding to brilliant entrepreneurs and companies across all sectors in Asia. The company backed these entrepreneurs and companies with unparalleled support in funding, management, overseas business development, and exposure to their network.
Show more...Investment focus
- Industry: Software, Information Technology, Education
- Stage:Seed, Angel, Series A
- Geography: Japan, Taiwan, Hong Kong
Investor stats
- Total investments: 11
- Round size: Seed $275k–$1.2M; Series A $2.7M–$10M
- Lead/follow: 27% lead, 73% follow
- Last fund: May invest from a new fund soon — raised $10M in 2014
Portfolio highlights
- Flyspaces — FlySpaces empowers businesses as a digital marketplace that provides short-term work and meeting space solutions to entrepreneurs, start-ups, SMEs and mobile professionals. Whether the need is for an hour, a day, a week or a few months - we have a network of hundreds of spaces to discover across key South East Asian cities.For venue owners,FlySpaces acts as a digital marketing platform that connects you to a vast user base, allowing you to optimize and monetize your space.We recognize that workspace is more than a mere location. It is a setting that inspires ideas, motivates action and promotes growth. With FlySpaces, find where your business will accomplish its next milestone.FlySpaces empowers businesses as a digital marketplace that provides short-term work and meeting space solutions to entrepreneurs, start-ups, SMEs and mobile professionals. Whether the need is for an hour, a day, a week or a few months - we have a network of hundreds of spaces to discover across key South East Asian cities.For venue owners, FlySpaces acts as a digital marketing platform that connects you to a vast user base, allowing you to optimize and monetize your space.We recognize that workspace is more than a mere location. It is a setting that inspires ideas, motivates action and promotes growth. With FlySpaces, find where your business will accomplish its next milestone.
- Prenetics — CircleDNA is an at-home, non-invasive DNA test providing health insights across 500+ reports based on your unique genetic blueprint.
- HelloWings — "See" the cheapest fare, year-round and fees included. Customized combination tickets. HelloWings ensures you'll arrive to destination on budget & in style.
Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 256
- Round size: Series A $14M–$100M; Series B $25M–$110M; Series C $30M–$308M
- Lead/follow: 27% lead, 73% follow
- Last fund: May invest from a new fund soon — raised $40M in 2019
Portfolio highlights
- InventisBio — InventisBio is a biotech company whose product pipeline includes small molecule drug candidates for targeted therapies in lung cancer, breast cancer and gout. The company is also actively developing drugs that can be combined with other immune-oncology targeted therapies, such as PD-1 antibody, for various cancer indications. The company isco-founded by Dr. Yaolin Wang and other scientists who have previously worked at Merck and Schering-Plough, leading various drug discovery projects in oncology, metabolic and infectious disease areas.
- NeuShen Therapeutics — We are a global biotech company committed to developing new and effective therapies for psychiatric and neurological disorders affecting millions of patients in need.
- Connexus Therapeutics — Connexus Therapeutics is a private, venture-backed biotechnology company specializing in the discovery and development of next-generation small-molecule drugs for oncology treatment .
Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greater development space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services. Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns. Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise. By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B, Seed
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 192
- Round size: Seed $7.9M–$41M; Series A $4.4M–$47M; Series B $7.1M–$85M
- Lead/follow: 33% lead, 67% follow
- Last fund: May invest from a new fund soon — raised $204M in 2016
Portfolio highlights
- Inno Medicine — Inno Pharmaceutical Technology specializes in research on the pathogenesis of atherosclerosis. The company focuses on the development of targeted nanoliposomes, targeting molecules with independent intellectual property rights, and currently focuses on the plaque reversal treatment of atherosclerosis.
- Zhiran Medical — Zhiran Medical is a medical technology company specializing in the precise detection and treatment of neurological disorders using high-throughput, flexible brain-computer interface technology.
- MyoGene Life Sciences — MyoGene Life Sciences is a regenerative medical company that specializes in the promotion of its regenerative repair material product line for bone repair.
Groove Capital is a new investment firm targeting early-stage companies.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, Hong Kong, Mauritius
Investor stats
- Total investments: 143
- Round size: Seed $405k–$3.3M; Pre-Seed $100k–$1.7M
- Lead/follow: 8% lead, 92% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Q-rounds — Q-rounds is a virtual queue that sends real-time notifications to patients, families, nurses, and other stakeholders of when to arrive for rounds.
- Refr Sports — Welcome to Refr Sports, the world's fastest growing assigning solution. Our comprehensive suite of services saves you time and money while allowing you to be the assignor people love to work with.
- Ladder Health — Expert speech, occupational, physical, and feeding therapy for children, right from home, with flexible virtual visits and a plan that fits real life.
Founded in 2003, Hony Capital is a pioneer in China’s home grown private equity industry. Sponsored by Legend Holdings, a leading Chinese conglomerate, Hony has blazed the trail in formulating private equity investment strategies suitable for Chinese conditions by combining a deep understanding of local environment and people with global resources and international best practices. Today, with over USD 6.8 billion in assets under management across 7 funds and investments in over 60 companies, Hony is a leading China-focused private equity firm. Adhering to the “value creation” investment philosophy, Hony partners with managers and entrepreneurs to build their businesses into sustainable leaders in respective industries. Hony focuses on sectors where it has developed expertise: pharmaceuticals and healthcare, consumer & retail, media & entertainment, financial services, construction materials, machinery, and alternative energy & resources
Show more...Investment focus
- Industry: Manufacturing, Biotechnology, Medical
- Stage:Series A, Series B, Seed
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 93
- Round size: Seed $15M–$41M; Series A $6.6M–$390M; Series B $3.8M–$646M
- Lead/follow: 34% lead, 66% follow
- Last fund: May invest from a new fund soon — last raise in 2015
Portfolio highlights
- Biosensors — The Biosensors International group of companies develop, manufacture and market innovative medical devices for interventional cardiology and critical care procedures. Our aim is to improve patients' lives through pioneering medical technology that pushes forward the boundaries of innovation.
- Xingkeyuan — Star Science is a high-performance lithium battery silicon-carbon negative electrode material research and development company. It has achieved small-scale mass manufacture of nano-silicon as well as the experimental development of high-efficiency silicon-carbon composite materials.
- Zhongguancun Shuimu Medical Technology — Shuimu Medical is a third-party professional medical device inspection and testing institution.
Founded in 2009, Cowin Venture is an angel and early-stage investor in TMT and Healthcare. We keep nurturing growth-stage companies graduated from their angel investment portfolio. Cowin’s business network covers China and USA. They have offices in Suzhou, Nanjing, Shanghai, Beijing and Hong Kong.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Angel, Series B
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 106
- Round size: Angel $52k–$1.9M; Series A $1.6M–$25M; Series B $3M–$257M
- Lead/follow: 23% lead, 77% follow
Portfolio highlights
- Genta Kyushu Bio — Genta Kyushu Bio is a cutting edge biotechnology company specializing in the development of precision neuro circuit therapies for central nervous system and ophthalmic diseases. The firm leverages its high throughput screening and drug development platforms to advance innovative treatments utilizing chemogenetics, optogenetics, and gene therapies.
- Zhaomo Vacuum — Zhaomo Vacuum is an enterprise integrating R&D, production, commissioning, and service of vacuum chambers.
- StringMotion Future — StringMotion Future focuses on the core technology research and development of tendon-inspired chord-driven robots, creating advanced robotic systems designed to deliver greater flexibility, precision, and efficiency for industrial and intelligent automation applications.
HSG is a leading venture capital and private equity firm investing globally in the technology, healthcare, and consumer sectors.
Show more...Investment focus
- Industry: Artificial Intelligence, Health Care, Software
- Stage:Series A, Series B, Seed
- Geography: China, United States, Singapore
Investor stats
- Total investments: 1144
- Round size: Seed $2M–$50M; Series A $2M–$100M; Series B $10M–$200M
- Lead/follow: 45% lead, 55% follow
- Last fund: Likely still investing — raised $2.5B in 2024
Portfolio highlights
- Z.ai — Z.ai develops artificial intelligence models and services built upon large-scale pretrained architectures. The company offers ChatGLM, a dialogue-focused language model series designed for smooth conversation and easy integration. It also provides Ying, a text-to-video model capable of generating short video clips from text or images, and AutoGLM,a voice-driven AI agent that performs smartphone tasks based on complex user instructions. Z.ai supports integration through an API platform and offers migration assistance for developers moving from other AI ecosystems. The company’s technology stems from research at Tsinghua University’s KEG lab and emphasizes general-purpose cognitive intelligence models.
- Xinghuo Chenguang — Xinghuo Chenguang is a hard-tech company focusing on semiconductor chips and optoelectronic interconnect technologies.
- Suisheng Technology — Suisheng Technology is an innovative company specializing in AI-driven memory services, dedicated to developing intelligent solutions that help individuals and businesses capture, organize, and retrieve important information with greater efficiency and precision.
Organizing and investing in a global army of entrepreneurs committed to achieving health moonshots
Show more...Investment focus
- Industry: Health Care, Medical, Wellness
- Stage:Seed, Venture - Series Unknown, Pre-Seed
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 407
- Round size: Seed $100k–$3.5M; Pre-Seed $20k–$854k; Venture - Series Unknown $150k–$15M
- Lead/follow: 3% lead, 97% follow
- Last fund: May invest from a new fund soon — raised $31M in 2018
Portfolio highlights
- AvoMD — AvoMD is reimagining clinical decision support with interactive point-of-care software, available standalone and via EHR integrations, and seamless content building tools.
- Hidoc Consult — Hidoc Consult: Boost your well-being with free consultations, 24/7 access to quality healthcare, complete privacy, user-friendly, and a trusted network of HCPs
- NEXT Life Sciences — NEXT Life Sciences is developing the revolutionary Plan A™ procedure to bring the only scientifically proven technology in the category - Vasalgel® - to market.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Welcome to Arkansas Development Finance Authority (ADFA), your source for safe, decent, affordable housing in Arkansas. Contact us at (501) 682-5900 to secure your dream home today!
Show more...Investment focus
- Industry: Medical, Biotechnology, Manufacturing
- Stage:Venture - Series Unknown, Seed, Pre-Seed
- Geography: United States
Investor stats
- Total investments: 6
- Round size: Venture - Series Unknown $2M–$35M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Pacific GeneTech — Pacific GeneTech Improving human life through biotech and animal health solutions
- BlueOak Resources — BlueOak: Sourcing Metals Sustainably™ from End-of-Life Electronics.BlueOak believes in the philosophy of resource and capital efficiency. They are building distributed mini-refineries that use proven, capital-efficient refining processes towards extracting precious metals and rare earth elements from e-waste. Their vision is to revolutionize howwe treat end of life electronics: converting the e-waste of today into a sustainable source of critical metals and rare earths for the technologies of tomorrow.
- United States Steel — U. S. Steel Home Page
Picus Capital is an early-stage technology investment firm with a long-term investment philosophy. We work together with daring technology companies to build successful, global companies challenging the status quo and shaping tomorrow.
Show more...Investment focus
- Industry: Software, Financial Services, FinTech
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Germany, United Kingdom
Investor stats
- Total investments: 454
- Round size: Seed $1.6M–$11M; Pre-Seed $563k–$4.5M; Series A $3.9M–$34M
- Lead/follow: 19% lead, 81% follow
- Last fund: Likely still investing — raised $140M in 2024
Portfolio highlights
- Enpal — Kostenlose Planung von Solaranlagen. Gewinnbringende & schnelle Umsetzung von Photovoltaikanlagen inklusive professionelle Installation & Netzanschluss. Zum Festpreis!
- Lightbase — An always up-to-date view of your entire IT ecosystem for faster decisions and confident transformation at scale
- Spot My Energy — The uptake of PV, EVs, home storage, and heat pumps leads to a gigantic need for digital and intelligent metering and for the integration of millions of...
FEBE Ventures (“For Entrepreneurs, By Entrepreneurs”) is an early stage Venture Capital fund supporting outstanding entrepreneurs in Vietnam & Southeast Asia. The fund is managed by 4 entrepreneurs with +28 years of experience building and scaling companies in Vietnam & Southeast Asia, and investing in tech startups in Asia, Europe andSouth America. We apply a value-added approach, backing the best founders and offering our local business expertise, operational know-how, and global network.
Show more...Investment focus
- Industry: FinTech, Financial Services, Software
- Stage:Seed, Series A, Pre-Seed
- Geography: Singapore, Indonesia, Vietnam
Investor stats
- Total investments: 67
- Round size: Seed $1.5M–$6.4M; Pre-Seed $400k–$2.4M; Series A $6M–$40M
- Lead/follow: 10% lead, 90% follow
- Last fund: Likely still investing — raised $75M in 2023
Portfolio highlights
- SixSense — SixSense is an AI-powered industrial visual inspection platform for smarter manufacturing. SixSense uses cutting-edge technologies in the field of AI such as deep learning and computer vision to automatically identify defects on the manufacturing floor. They are building the future of self-intelligent factories by enabling automation forimage-based industrial applications.
- SoBanHang (Finan Pte. Ltd.) — SoBanHang helps small and micro businesses build online stores, reach more customers and manage cashflow effortlessly on smartphones
- HD — Guiding patients to the right next step and connecting them to real-world care with AI. Trusted by 500k+ patients and 3k+ providers.
Med-Fine Capital is a venture capital firm focusing on early stage investments in China healthcare industry. The company is headquartered in Shanghai with offices in Beijing and Shenzhen.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Series A, Seed, Series B
- Geography: China, Hong Kong, United States
Investor stats
- Total investments: 84
- Round size: Seed $8M–$60M; Series A $3M–$40M; Series B $12M–$50M
- Lead/follow: 32% lead, 68% follow
- Last fund: May invest from a new fund soon — raised $73M in 2019
Portfolio highlights
- Deepin Medical — Deepin Medical is dedicated to developing intelligent gadgets that address all aspects of surgery under a microscope.
- Zhuanma Biotech — Zhuanma Biotechnology is a gene editing service provider dedicated to clinically developing effective ultra-small gene editors into genetic therapeutics that are "curable once and for all."
- Beijing Ansong Technology — Beijing Ansong Technology Co., Ltd. is an enterprise focusing on the research and development, production, and sales of orthopedic medical devices. The company cooperates with domestic and foreign universities, research institutes, and doctors in hospitals, and is committed to creating original orthopedic products with independent knowledgeproducts.Beijing Ansong Technology was founded on June 27, 2011 by Liang Tao in Fengtai, Beijing.
FHB Ventures is a venture capital firm.
Show more...Investment focus
- Industry: Agriculture, AgTech, Medical
- Stage:Seed, Series A, Series B
- Geography: United States
Investor stats
- Total investments: 4
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- EarthOptics — GroundTruth Ag is a soil cloud creator specializing in sustainable agricultural management. GroundTruth offers insights into soil management and health as well as near-real-time actionable data layers that cover the physical, chemical, and biological characteristics of the soil. This technology allows farmers to obtain accurate soil informationwhile also offering carbon creditors low-cost, hyper-accurate verification.
- Pacific GeneTech — Pacific GeneTech Improving human life through biotech and animal health solutions
Vectr is a venture firm based in Hong Kong. They combine investment, creation and growth to deliver game-changing impact to teams ready to tackle global issues, transform industries and improve the lives of millions.That combines capital, creation and partnership to deliver game-changing impact. We strive to be the ideal partner for founders that are building transformation products and looking to expand their businesses into asia.
Show more...Investment focus
- Industry: FinTech, Financial Services, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: United States, Hong Kong, Singapore
Investor stats
- Total investments: 81
- Round size: Seed $547k–$6.5M; Series A $1M–$37M; Series B $12M–$70M
- Lead/follow: 21% lead, 79% follow
Portfolio highlights
- Airstack — Every day there are millions of blockchain transactions. Airstack makes sense of them.
- Micro Connect — Micro Connect provides market infrastructure, fintech, and platform development.
- MasterExchange — Trading platform for music rights leveraging emerging technology to create friction free and compliant investment opportunities to everyone.
Novel Tycoon
Show more...Investment focus
- Industry: Nutrition, Organic Food, Food Processing
- Stage:Seed
- Geography: Hong Kong
Investor stats
- Total investments: 2
- Round size: Seed $1.3M–$1.3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Future salad — Future Salad is a Hong Kong food tech startup combining nature and technology.
Whist Subholdings is a venture capital investment firm.
Show more...Investment focus
- Industry: Medical, Agriculture, Health Care
- Stage:Seed, Venture - Series Unknown
- Geography: United States
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Pacific GeneTech — Pacific GeneTech Improving human life through biotech and animal health solutions
Chartwell Ventures is an investment firm.
Show more...Investment focus
- Industry: Nutrition, Organic Food, Food Processing
- Stage:Seed
- Geography: Hong Kong
Investor stats
- Total investments: 2
- Round size: Seed $1.3M–$1.3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Future salad — Future Salad is a Hong Kong food tech startup combining nature and technology.
Simmons Foods is a leading supplier of poultry, pet and ingredient products based in Siloam Springs, Arkansas.
Show more...Investment focus
- Industry: Medical, Agriculture, Health Care
- Stage:Seed, Venture - Series Unknown
- Geography: United States
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Pacific GeneTech — Pacific GeneTech Improving human life through biotech and animal health solutions
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!AAIC Ventures focuses on companies with management, technology, and production in Asia, addressing a global market. AAIC Ventures believes that it is in the midst of a technological revolution and Asia, where it has its connections and experience, will play a pivotal role. At the heart of its AAIC Ventures' involvement in start-ups is the drive to support their development, innovation process and growth with both advice and hands-on involvement. Developing good ideas into a marketable product and process requires incredible innovation and creativity. AAIC Ventures likes to challenge the status quo and take an active role in finding alternative ways for our companies to achieve their goals. AAIC Ventures combines its work with its portfolio companies with serious capital commitments, often participate in follow-on rounds, and help in all aspects of further capital raising efforts.
Show more...Investment focus
- Industry: Medical, DIY, iOS
- Stage:Seed, Series A
- Geography: Hong Kong, Egypt, Kenya
Investor stats
- Total investments: 8
- Round size: Seed $500k–$1.8M; Series A $350k–$2M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Leodan — Using over 15 years’ experience of past practical technology implementations, Leodan enhances the competitiveness of organisations’ processes and systems through advising on implementing and improving Automatic Identification and Data Capture technology.With experience of over 100 Auto ID and IT implementations in private and public sector, theyare well positioned within Asia Pacific region to assist organisations in improving process control within the logistics, supply chain, manufacturing, healthcare and government sectors.
- Rology — AI-assisted On-demand Teleradiology Platform
- Lami — Lami is an end-to-end digital insurance platform and API that enables companies across sectors to offer insurance products. Its API allows underwriters to connect with consumer-facing companies that can provide embedded insurance as a value add for existing customers, many of whom are uninsured.
PT Medion is a venture capital investment firm.
Show more...Investment focus
- Industry: Medical, Agriculture, Health Care
- Stage:Seed, Venture - Series Unknown
- Geography: United States
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Pacific GeneTech — Pacific GeneTech Improving human life through biotech and animal health solutions
Seveno Capital is an investment fund backing early and growth-stage ventures that have the holistic potential to increase the human healthspan.
Show more...Investment focus
- Industry: Sensor, Travel, Wearables
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: Japan, Hong Kong, United Kingdom
Investor stats
- Total investments: 4
- Lead/follow: 75% lead, 25% follow
Portfolio highlights
- A Cabin Company — A cabin company is a company that creates and operates small, attractively built cottages located in rural or semi-rural locations. These cabins are designed to promote human health and wellness by providing access to healing natural environments.
- PointFit Technology — Tailor your fitness journey with our non-invasive skin patch. We are empowering individuals worldwide by providing real-time, actionable insights.
- Longevity Technology — Longevity Technology is a daily news and insights on research, investments and technologies that extend life.
Capital Union Investments is a leader in private investment for early stage, growth, mezzanine, and pre-IPO capital. Headquartered in Hong Kong; and with offices in China and the US, the Firm's investment philosophy has been to create value by identifying leaders and innovators, whose businesses that can be developed in Asia. Our approach of providing unique investment insights, local knowledge and value-added operating capabilities, differentiates us from many traditional private investment funds.
Show more...Investment focus
- Industry: Health Care, Marketing, Personal Health
- Stage:Seed, Series A, Series B
- Geography: United States, Hong Kong
Investor stats
- Total investments: 10
- Round size: Seed $150k–$10M; Series A $2.7M–$10M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- Moocho — About Moocho:Created by members of StubHub’s founding team, Moocho is the leading college rewards and payment app. With Moocho, college students pay with their phone at all their favorite merchants on and around campus and earn exclusive rewards and discounts for doing so. Moocho partners directly with universities to provide their studentswith an innovative product and acts as the de facto college marketing arm of its merchant partners, helping them drive more business and understand their customers better.Moocho is based in The LAB, the entrepreneurial hub of Miami’s Wynwood neighborhood. Moocho's management team has a track record of local, entrepreneurial E-commerce success, delivering relevant content to college students, managing large distributed campus operations, and running several rapid-growth, profitable companies. Read more about Moocho here: www.moocho.com
- Surkus — Surkus is a product discovery app where DTC businesses can source feedback and content creation from consumers by offering free or heavily discounted products.
- Dash Living — Dash Living is Asia's flexible living provider in Hong Kong, Singapore, and Japan. Furnished apartments, serviced apartments, hotels, and coliving spaces with all-inclusive rates for monthly & nightly stays.
A collection of entrepreneurs, engineers, physicists, doctors, surfers, and musicians who are committed to helping entrepreneurs achieve their dreams of changing the world.
Show more...Investment focus
- Industry: Health Care, Software, Biotechnology
- Stage:Series A, Series B, Seed
- Geography: United States, Hong Kong, India
Investor stats
- Total investments: 131
- Round size: Seed $2M–$15M; Series A $6M–$40M; Series B $15M–$58M
- Lead/follow: 21% lead, 79% follow
- Last fund: May invest from a new fund soon — last raise in 2017
Portfolio highlights
- Evergreen — Omeat is real, lip-smacking meat, grown from cells, outside the animal. No sacrifice required.
- KeyCare — KeyCare is a virtual care platform powered by Epic that was created to assist forward-thinking health systems in increasing patient access and quality by enhancing the alternatives available for virtual care.
- General Compute — General Compute provides an ASIC-based cloud inference platform focused on running AI inference workloads. The company offers an OpenAI-compatible API that allows users to access hosted large language models and switch from existing GPU-based providers by changing the base URL and API key. It supports deploying both its own supported models andcustomer-supplied models on its infrastructure, emphasizing high token throughput and low time to first token. General Compute also offers dedicated custom deployments with service-level agreements, custom scaling, and guaranteed capacity for production workloads. Its infrastructure targets use cases such as AI agents, coding assistants, and real-time voice applications that require low-latency, high-throughput inference.
Founded in 2005, Hillhouse is a leading global investment management firm, active across public equity, private equity, real estate and private credit. The firm invests over a long-term horizon and partners with exceptional entrepreneurs to deliver sustainable value creation for quality companies.Hillhouse is a full life-cycle private equityfirm, investing for the long term across opportunities in the healthcare, business services, consumer, and industrials sectors. The firm manages capital on behalf of global institutions such as non-profit foundations, endowments, and pensions.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Series B, Series A, Series C
- Geography: China, United States, Singapore
Investor stats
- Total investments: 331
- Round size: Series A $2.9M–$157M; Series B $15M–$230M; Series C $15M–$220M
- Lead/follow: 38% lead, 62% follow
- Last fund: May invest from a new fund soon — raised $11B in 2018
Portfolio highlights
- Sainte — Sainte is a company which provides professional nutritional solutions for babies with different nutritional needs
- Vita Dynamics — Vita Dynamics involves learning through real-world interactions by developing robots that can physically engage with their environment, they can adapt more naturally and efficiently.
- NeueHCT — Horizon Continental Technology is a joint venture between Continental Group and Horizon Robotics
Vector Ventures is a early stage digital health + medical device investment fund
Show more...Investment focus
- Industry: Mining, Nutrition, Oil and Gas
- Stage:Seed
- Geography: Hong Kong
Investor stats
- Total investments: 2
- Round size: Seed $1.3M–$2M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Future salad — Future Salad is a Hong Kong food tech startup combining nature and technology.
- viAct — viAct optimises construction safety, productivity and environmental compliance. Ensuring higher ESG preposition with AI. Offering services for construction industry of Asia & Europe & operational in China, Singapore, Japan, Australia, Vietnam, Indonesia and Hong Kong.
Founded in 2000, Emerging Technology Partners (“ETP”) is a life sciences focused investment fund with a cross border investment focus. ETP was founded with a simple mission: to provide capital and assist management in building and commercializing breakthrough diagnostic and therapeutic products in the fields of life sciences, while providingsuperior returns to their investors.ETP supports their portfolio companies facilitate strategic alliances including cross-border partnerships, recruit management, and acquire new products and technologies to accelerate growth in both US and China. They have investment partners in San Francisco, Boston, Washington DC, and Beijing.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B, Seed
- Geography: United States, China, Hong Kong
Investor stats
- Total investments: 17
- Round size: Seed $1M–$3.5M; Series A $8.3M–$30M; Series B $3.4M–$40M
- Lead/follow: 41% lead, 59% follow
Portfolio highlights
- Human Longevity — Human Longevity (HLI) is the genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived. HLI combines the largest database of genomic and phenotypic data with machine learning to drive discoveries and revolutionize the practice of medicine. Its business areas include the HLI Health Nucleus, a genomicpowered clinical research center that uses whole-genome sequence analysis, advanced clinical imaging, and innovative machine learning, along with curated personal health information to deliver the most complete picture of individual health; HLIQ Whole Genome and HLIQ Oncology. It was founded in 2013 and is headquartered in San Diego, California.
- CASI Pharmaceuticals — CASI is a NASDAQ-listed biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products.
- Qiu Shui Semiconductor — Qiu Shui Semiconductor is a semiconductor company that specialized on Micro-LED display technology.Qiu Shui Semiconductor's core products are Micro-LED micro display chips and modules, which are widely utilized in digital car lighting, micro projection, and augmented reality displays.
WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. As an innovation-driven and customer-focused company, WuXi AppTec helps our partners improve theproductivity of advancing healthcare products through cost-effective and efficient solutions,With industry-leading capabilities such as R&D and manufacturing for small molecule drugs, cell and gene therapies, and testing for medical devices, WuXi AppTec's open-access platform is enabling more than 3,900 collaborators from over 30 countries to improve the health of those in need – and to realize our vision that "every drug can be made and every disease can be treated".
Show more...Investment focus
- Industry: Biotechnology, Pharmaceutical, Health Care
- Stage:Series A, Series B, Series C
- Geography: United States, China, Israel
Investor stats
- Total investments: 45
- Round size: Series A $6M–$90M; Series B $21M–$130M; Series C $30M–$40M
- Lead/follow: 18% lead, 82% follow
- Last fund: May invest from a new fund soon — raised $250M in 2015
Portfolio highlights
- D3 Bio — D3 Bio is a globally focused biotechnology company focusing on developing and registration of innovative medicines in oncology and immunology. At D3 Bio, our new medicine development approach is fundamentally differentiated. We do not just only start with science in the lab. First, we pinpoint the greatest unmet patient and market needs – whereexisting standard-of-care approaches yield unsatisfactory clinical outcomes. Then we take those insights into the lab to guide the identification of fit for purpose science and technology and define our drug development path.
- ShouTi — ShouTi specializes in the discovery and development of drugs against a type of targets called GPCR. The company develops drugs focused on novel small molecules for multiple unmet medical needs. ShouTi is currently operating in Stealth mode.
- Bioyond Tech — Bioyond Tech utilizes robotics and artificial intelligence technology to provide a new generation of modular products and automation solutions for the life sciences sector.
Make the right startup move by using our startup tools, guides, calculators and templates. Learn from other successful entrepreneurs by reading our case studies
Show more...Investment focus
- Industry: Biopharma, Life Science, Biotechnology
- Stage:Series A
- Geography: Hong Kong
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Great Bay Bio — Great Bay Bio Ltd. is a high-tech company that develops blue ocean biopharmaceuticals with a digital platform. It has a long history of biomedical research and development and rich experience in product development. Adhering to the national strategic concept of scientific and technological innovation and coordinated development of the Greater BayArea, Dawan Biotechnology brings together high-quality resources from Europe, the United States, Singapore, and Hong Kong to build a biopharmaceutical development platform centered on AI technology, big data, and Internet of Things technology, which greatly shortens The drug development cycle significantly reduces development costs and has great industry competitive advantages.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!AEF Greater Bay Area Fund is an investment fund.
Show more...Investment focus
- Industry: Biotechnology, Sports, Sustainability
- Stage:Seed, Series A, Series B
- Geography: Hong Kong, China, Macao
Investor stats
- Total investments: 11
- Lead/follow: no public data
Portfolio highlights
- ORCA-TECH — ORCA-TECH is a manufacturer of self-driving boat.
- SleekFlow — SleekFlow makes customer messaging apps such as WhatsApp and Facebook connected to one platform for teams to better support and engage customers.
- Scolioscan — Scolioscan focuses on medical imaging technology research & development, self-service production and technology distribution and promotion.
First we help. Then we invest. Together we rise.
Show more...Investment focus
- Industry: Software, SaaS, Machine Learning
- Stage:Seed, Convertible Note, Angel
- Geography: United States, Canada, Italy
Investor stats
- Total investments: 50
- Lead/follow: no public data
Portfolio highlights
- FleetPanda — 100% cloud and smart phone based. No hardware, No install required. Try for 2 weeks before you buy.
- HouseKeys — HouseKeys is a for-profit / nonprofit hybrid focused on the economic empowerment of income-eligible households seeking affordable housing options for rent or purchase in high-cost metro and rural areas. We began in 2015, serving as a 3rd-Party contracted Housing Department for Bay Area cities who needed staffing and systems to run theirhousing programs. The next iteration of our company will be to grow our database of low-to-moderate income households and connect them with housing opportunities in California, nationwide, and urbanizing metro areas throughout the world.
- Aerotrax — The Next Generation of Aircraft Maintenance Software. Aerotrax is an enterprise software company focused on digitally tracking the lifecycle of every aircraft, part, and component.
Prytek is a technological infrastructure as a service group driven by AI. Prytek builds vertically integrated ecosystems by combining top tier managed service companies and leading proprietary technologies under one roof via a decentralized organizational structure. We build infrastructure, outsource operations and provide managed services forFinancial institutions, Universities, and Enterprises. The group is divided into two arms: the Corporate Arm which comprises of controlled service companies and the Technology Arm which comprises of minority stakes in start-up tech companies. The goal of the Corporate Arm is to build businesses, while the Technology Arm’s goal is to develop products for the Corporate Arm and generate equity value for Prytek.
Show more...Investment focus
- Industry: Software, FinTech, Information Technology
- Stage:Series A, Seed
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 34
- Lead/follow: no public data
Portfolio highlights
- ThriveDX — Enter the world's premier EdTech provider and discover ThriveDX's cyber security training and digital skills programs. Contact us to learn more!
- CYREBRO — CYREBRO is your online centralized interactive SOC platform that integrates all your security events with strategic monitoring, threat intelligence and IR
- TritonExec — TritonExec is a global executive search firm specializing in chief executive, board & senior talent for businesses experiencing growth
Betatron Venture Group is a venture capital firm that invests in early-stage companies.
Show more...Investment focus
- Industry: Information Technology, Software, E-Commerce
- Stage:Seed, Series A, Pre-Seed
- Geography: Hong Kong, India, Singapore
Investor stats
- Total investments: 41
- Lead/follow: no public data
Portfolio highlights
- Baskit — baskit | Empowering wholesalers and distributors with the world's first cloud-native all-in-one app
- Botsync — Botsync builds autonomous mobile robots to automate and digitize movement of goods from point to point for the logistics and manufacturing industry. Our robots can carry payloads from 500 kg to 1 tonne and are designed to operate in dynamic environments. Botsync's AMRs can be implemented at new facilities in minimal time with very minimalchanges to the existing infrastructure. With our technology, we hope to pioneer and push for larger scale adoptions of robotic automation in Asia's logistics and manufacturing industry.
- Varadise — Varadise is a digital twin platform offering technology services, cloud platforms, and business services comprising IoT and AI.
We extend healthy lifespan through developing innovative medicines that target core aging mechanisms to not only treat but prevent age-related diseases.
Show more...Investment focus
- Industry: Biotechnology, Pharmaceutical, Health Care
- Stage:Series A, Debt Financing
- Geography: United States, Hong Kong, Isle of Man
Investor stats
- Total investments: 13
- Round size: Series A $3M–$19M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- LyGenesis — LyGenesis is an organ regeneration company enabling a patient's own lymph nodes to be used as bioreactors to regrow functioning ectopic organs. Their initial target organ for clinical development is liver regeneration, with a focus on helping patients with end stage liver disease (ESLD).
- MDI Therapeutics — MDI Therapeutics is an operator of a discovery stage company focused on developing novel therapies for fibrotic diseases. The company have developed a proprietary discovery platform which has successfully identified novel small molecule and protein drug candidates, and have advanced these programs through key translational experiments usingclinical biomarkers.
- Souvien Therapeutics — Souvien Therapeutics is a biotechnology company focused on developing therapeutic agents to modulate critical epigenetic mechanisms associated with neurodegeneration.
SFUND is a social investment and financing platform specially established for social investment and strengthening the status of regional financial centers.
Show more...Investment focus
- Industry: Manufacturing, Agriculture, Medical Device
- Stage:Angel, Series A, Post-IPO Equity
- Geography: China, Hong Kong, United States
Investor stats
- Total investments: 32
- Lead/follow: no public data
Portfolio highlights
- Mymro — Mymro engages in providing digital supply chain procurement solutions.
- Lehe Food — Guangdong Lehe Food Co., Ltd. now has more than a dozen distribution centers, relying on the management headquarters in Guangzhou to provide standardized and professional management to the companies that are constantly replicating and expanding throughout the country through reasonable shareholding structure and standardized corporate governance.Services; its industries cover farm operation management, agricultural planting and breeding, agricultural product processing and distribution, catering management, high-end agricultural products online mall, agricultural information technology consulting, etc. The business area has basically covered Guangdong, Hainan, Yunnan and Shanghai. And accelerate the expansion to other key areas of the country.
- Juwan Technology — Juwan Technology Research Institute is the first in-house incubation technology innovation company of GAC Group.
Maverick Ventures is the venture arm of multi-billion dollar investment firm Maverick Capital. Combining the resources of a global firm with the benefits of an agile, focused team, Maverick Ventures supports entrepreneurs from seed through maturity. With over 30 years of early-stage investment experience, the Maverick Ventures team has funded morethan 100 companies in the healthcare, software and deep technology sectors. The highly-experienced team of operating executives and investors at Maverick Ventures generally lead rounds, take board seats and work with management to build successful enterprises.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Series C, Seed
- Geography: United States, Israel, India
Investor stats
- Total investments: 171
- Lead/follow: no public data
Portfolio highlights
- Proximie — Proximie enables healthcare organizations, surgeons, and medical device companies to improve patient safety, scale training efforts, and accelerate device adoption, all while driving substantial savings in cost and time.
- HumanFirst — HumanFirst enables better integration and analysis of digital health technologies in clinical trials.
- Nourish — Achieve your desired health and wellness through personalized nutrition counseling. Nourish is the easiest way to find a registered dietitian and get it covered by your insurance. Find a dietitian today and start your telehealth appointments.
Cowin Capital is a private placement equity investment company focusing on investing in a pioneering enterprise on a long-term basis. It has 18 years of experience in capital management, whose capital management scale was among the front rank, which invested more than 300 companies, of which 60 more became public companies, and 150 moresuccessfully exit.The company was successfully listed on NEEQ, with code 832793, as the third listed famous domestic venture capital institution in NEEQ. It is committed to supporting the growth of small and medium enterprises, continue to launch high-quality listed companies in China Capital Market.
Show more...Investment focus
- Industry: Manufacturing, Health Care, Biotechnology
- Stage:Series A, Series B, Seed
- Geography: China, Hong Kong, United States
Investor stats
- Total investments: 264
- Round size: Seed $1.4M–$20M; Series A $4.3M–$43M; Series B $2.8M–$50M
- Lead/follow: 45% lead, 55% follow
- Last fund: May invest from a new fund soon — raised $75M in 2014
Portfolio highlights
- HUAUN — HUAUN is a security vendor that focuses on vulnerability management and AI offense and defense.
- Sinsegye — Sinsegye operates as a product-driven enterprise company. Sinsegye is an industrial control supercomputing infrastructure supplier.
- Digital China — Digital China is a robotics company focused on developing humanoid interactive robots that can break traditional boundaries and create emotionally resonated partners.
DNA Capital is an investment partnership specializing in multi-stage investments in the healthcare sector.
Show more...Investment focus
- Industry: Health Care, Medical, Hospital
- Stage:Seed, Series A, Series B
- Geography: United States, Brazil, China
Investor stats
- Total investments: 37
- Round size: Seed $250k–$8M; Series A $2M–$30M; Series B $3.6M–$30M
- Lead/follow: 49% lead, 51% follow
Portfolio highlights
- Memed — The safest and friendliest e-prescribing tool, for doctors. The most convenient and affordable way for treatment adherence, for patients.
- Reema Health — Transforming the way people navigate the gaps between health care and social care. Reema combines a 24/7 AI-based confidant with in-person community guides to help people meet their social needs.
- Feegow Clinic — Feegow Clinic is a clinical software that serves as a solution to all clinical and office management problems. The company exists since 2009 with the purpose of optimizing the routine of clinics, offices and hospitals throughout Brazil. Feegow Clinic meets the real needs of its audience, made up of different profiles in the health area.
Anhui USTC iFLYTEK Science and Technology Co., Ltd. (科大讯飞) is a software enterprise focused on the research of intelligent speech and language technologies, development of software and chip products, provision of speech information services, and integration of e-government systems.As a key supplier of intelligent speech technologies, USTCiFLYTEK holds long-term research experience in the field of intelligent speech technologies, and reputed achievements in a variety of technologies such as speech synthesis, speech recognition and spoken language evaluating.
Show more...Investment focus
- Industry: Artificial Intelligence, Information Technology, Software
- Stage:Series A, Angel, Seed
- Geography: China, Hong Kong
Investor stats
- Total investments: 82
- Round size: Seed $142k–$99M; Angel $425k–$21M; Series A $1.4M–$15M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- Liangyi Wanxiang — Liangyi Wanxiang is focuses on complete machines, product R&D, and technological innovation in atomic quantum computing.
- Chengdu RainZhiLingdong Technology — Chengdu RainZhiLingdong Technology is a robotics company that offers an AI powered bionic plush pet toy.
- Anhui Xinglian Artificial Intelligence Technology — Anhui Xinglian Artificial Intelligence Technology develops artifical intelligence application software.
Health Care VC funding in Hong Kong at a glance
Stats across 190 deals from 309 investors.
Access all 309 VC funds in Hong Kong Health Care startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Health Care VC Funds in Hong Kong investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 309 VC funds investing in Hong Kong Health Care startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!